Citadel Advisors’s Infusive Compounding Global Equities ETF JOYY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-57,411
Closed -$1.55M 14823
2022
Q1
$1.55M Buy
57,411
+2,603
+5% +$73.4K ﹤0.01% 6654
2021
Q4
$1.69M Sell
54,808
-3,400
-6% -$110K ﹤0.01% 6630
2021
Q3
$1.87M Buy
58,208
+28,242
+94% +$952K ﹤0.01% 6540
2021
Q2
$1.05M Buy
+29,966
New +$1.04M ﹤0.01% 8236

Citadel Advisors's JOYY Position: Q2 2022 in Review

Citadel Advisors sold out of Infusive Compounding Global Equities ETF (JOYY) in Q2 2022, closing a stake of 57,411 shares — an estimated $1.55M sold.

Citadel Advisors first reported a position in JOYY in Q2 2021 and held it in 4 quarters. The position peaked at $1.87M in Q3 2021. 0 funds tracked by Wall St. Rank hold JOYY as of Q2 2022.

  • Citadel Advisors reported no remaining Infusive Compounding Global Equities ETF position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 57,411 Infusive Compounding Global Equities ETF shares in Q2 2022, an estimated $1.55M.
  • Citadel Advisors first reported a position in Infusive Compounding Global Equities ETF in Q2 2021 and held it in 4 quarters.
  • Citadel Advisors's Infusive Compounding Global Equities ETF position peaked at $1.87M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Infusive Compounding Global Equities ETF as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.